ADMA Biologics, Inc. ( ADMA) - Stock Earnings
ADMA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
ADMA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 49.4 million USD | 139.2 million USD |
| 2026Q1 | 45.3 million USD | 114.5 million USD |
| 2026Q2 | 37.8 million USD | 124.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ADMA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.2 million USD | 258.2 million USD |
| 2024 | 197.7 million USD | 426.5 million USD |
| 2025 | 146.9 million USD | 510.2 million USD |
| 2026 Est. | — | — |
ADMA
Price: $10.18
Earnings Per Share: 0.70 USD
P/E Ratio: 14.15
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.7 million
Ebitda: -13.6 millionMarket Capitalization: 2.4 billion